When solutions exist, suffering shouldn't. We’re on a mission to restore comfort, dignity, and hope to breast cancer patients who have inoperable local recurrence and are left behind by today’s treatment options. Wiradia is investigating the potential to introduce a water-filtered Infrared-A (wIRA®) hyperthermic radiosensitizer to the US, which would make re-irradiation a viable treatment option for patients who would otherwise be ineligible. In European clinical practice, leading university cancer hospitals use wIRA with low-dose re-irradiation to support meaningful tumor control while helping reduce treatment-related toxicity in heavily pre-treated patients. In the US, Wiradia’s device is investigational and limited by US law to investigational use. It is not available for commercial distribution in the US. Wiradia LLC is a partner of Heckel Medizintechnik GmbH and Hydrosun Medizintechnik GmbH.
| Website | https://wiradia.com/ |
| Employees | 2 (2 on RocketReach) |
| Founded | 2025 |
| Industry | Medical Equipment Manufacturing |
Looking for a particular Wiradia employee's phone or email?
Wiradia Questions
Bob Mulhern is the Founder and Chief Executive Officer of Wiradia.
2 people are employed at Wiradia.
Wiradia is based in Cambridge, Massachusetts.
Top Wiradia Employees
-
Bob Mulhern
Founder and Chief Executive Officer at Wiradia
Boston, MA, US2 -
Anne Kenney
Chief Marketing and Education Officer at Wiradia
New York, NY, US35+
